Genetic variations of hepatitis B virus

Current Opinion in Infectious Diseases

Volumn 13, Issue 5, 2000, Pages 481-487

  Tong, C Y William ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; IMMUNOGLOBULIN; MEMBRANE ANTIGEN;

DIAGNOSTIC ACCURACY; DISEASE COURSE; DISEASE SEVERITY; GENETIC VARIABILITY; HEPATITIS B VIRUS; IMMUNIZATION; NONHUMAN; REVIEW; VIRAL GENETICS;

EID: 0033755729     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001432-200010000-00009     Document Type: Review

References (56)

1. Infection chains and evolution rates of hepatitis B virus in cardiac transplant recipients infected nosocomially
2. Typing hepatitis B virus by homology in nucleotide sequence: Comparison of surface antigen subtypes
3. Comparison of the amino acid sequences of nine different serotypes of hepatitis B surface antigen and genomic classification of the corresponding hepatitis B virus strains
4. Genetic relatedness of hepatitis B viral strains of diverse geographical origin and natural variations in the primary structure of the surface antigen
5. Genotyping of hepatitis B virus by restriction pattern analysis of a pre-S amplicon
6. The predominant genotypes of hepatitis B virus in Thailand
7. A new genotype of hepatitis B virus: Complete genome and phylogenetic relatedness
8. Relationships within and between genotypes of hepatitis B virus at points across the genome: Footprints of recombination in certain isolates
9. Detection of hepatitis B virus infection in wild-born chimpanzees (Pan troglodytes verus): Phylogenetic relationships with human and other primate genotypes
10. Genotypic differences in the hepatitis B virus core promoter and precore sequences during seroconversion from HBeAg to anti-HBe
11. Mutations in the pre-core region of hepatitis B virus serve to enhance the stability of the secondary structure of the pregenome encapsidation signal
12. Genotype F prevails in HBV infected patients of Hispanic origin in Central America and may carry the precore stop mutant
13. Core promoter mutations and genotypes in relation to viral replication and liver damage in East Asian hepatitis B carriers
14. Long-term mutation rates in the hepatitis B virus genome
15. Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection
16. Prevalence of precore mutants in anti-HBe-positive hepatitis B virus carriers in Germany
17. Naturally occurring variants of hepatitis B virus
18. Naturally occurring hepatitis B virus mutations with deletions in the core promoter region
19. Hepatitis B virus core promoter mutations in children with multiple anti-HBe/HBeAg reactivations result in enhanced promoter activity
20. Clinical implications of mutations C-to-T1653 and T-to-C/A/G 1753 of hepatitis B virus genotype C genome in chronic liver disease
21. Hepatitis B virus with mutations in the core promoter for an e antigen-negative phenotype in carriers with antibody to e antigen
22. Reduced transcription and progeny virus production of hepatitis B virus containing an 8-bp deletion in basic core promoter
23. Diversity of core promoter mutations in the immune clearance phase of chronic HBV infection
24. The enhancer J core region contributes to the replication level of hepatitis B virus in vivo and in vitro
25. Latent HBV infection in healthy individuals with antibody to HBcAg
26. Novel and frequent mutations of hepatitis B virus coincide with a major histocompatibility complex class I-restricted T-cell epitope of the surface antigen
27. Prevalence and significance of naturally occurring mutations in the surface and polymerase genes of hepatitis B virus
28. Vaccine-induced escape mutant of hepatitis B virus
29. A novel deletion mutant of hepatitis B virus surface antigen
30. High genetic variability of the group-specific a-determinant of hepatitis B virus surface antigen (HBsAg) and the corresponding fragment of the viral polymerase in chronic virus carriers lacking detectable HBsAg in serum
31. Hepatitis B mutations in the preS genome before and after liver transplantation
32. Two control elements in the hepatitis B virus S-promoter are important for full promoter activity mediated by CCAAT-binding factor
33. Hepatitis B virus genomes from long-term immunosuppressed virus carriers are modified by specific mutations in several regions
34. Properties of hepatitis B virus genome recovered from Vietnamese patients with fulminant hepatitis in comparison with those of acute hepatitis
35. Serial analysis of hepatitis B virus core nucleotide sequence of patients with acute exacerbation during chronic infection
36. Hepatitis B virus genomic sequence in the circulation of hepatocellular carcinoma patients: Comparative analysis of 40 full-length isolates
37. Hepatitis B virus strains with mutations in the core promoter in patients with fulminant hepatitis
38. Mutations in the basic core promoter and the precore region of hepatitis B virus and their selection in children with fulminant and chronic hepatitis B
39. Pre-S2 defective hepatitis B virus infection in patients with fulminant hepatitis
40. Changes of hepatitis B surface antigen variants in carrier children before and after universal vaccination in Taiwan
41. Unusual hepatitis B surface antigen variation in a child immunised against hepatitis B
42. Effect of hepatitis B virus mutants on efficacy of vaccination
43. Current status of HBV vaccine escape variants - A mathematical model of their epidemiology
44. Selection of hepatitis B surface 'escape' mutants during passive immune prophylaxis following liver transplantation: Potential impact of genetic changes on polymerase protein function
45. Immunoassay detection of hepatitis B surface antigen mutants
46. Effect of variation in the common 'a' determinant on the antigenicity of hepatitis B surface antigen
47. Nucleic acid amplification testing of hepatitis B. virus
48. Characterization of the reactivity pattern of murine monoclonal antibodies against wild-type hepatitis B surface antigen to G145R and other naturally occurring 'a' loop escape mutations
49. Quantitation of hepatitis B viremia and emergence of YMDD variants in patients with chronic hepatitis B treated with lamivudine
50. Novel patterns of amino acid mutations in the hepatitis B virus polymerase in association with resistance to lamivudine therapy in Japanese patients with chronic hepatitis B
51. Hepatitis B virus precore mutant infection is associated with severe recurrent disease after liver transplantation
52. Efficacy of lamivudine in patients with hepatitis B virus precore mutant infection before and after liver transplantation
53. Hepatitis B virus (HBV) mutations associated with resistance to lamivudine in patients coinfected with HBV and human immunodeficiency virus
54. In vitro evaluation of hepatitis B virus polymerase mutations associated with famciclovir resistance
55. Selection of multiresistant hepatitis B virus during sequential nucleoside-analogue therapy
56. Molecular epidemiology of hepatitis B virus mutants